HomeAbout CDU

Charles Drew University of Medicine and Science
Office of Development
1731 E. 120th Street
Los Angeles, CA 90059
Phone (323) 563-4992
Fax (323) 563-5987
Email alumni@cdrewu.edu

Random Image
Overview
Recent News and Publications
News Release
Articles & Books
Conferences
Research
About Dr. Ghoneum


In the News: Dr. Mamdooh Ghoneum

Dr. Mamdooh Ghoneum


A highly respected cancer researcher who discovered that non-pathogenic yeast holds a tremendous potential for a promising, natural cancer therapy.

 About the Man

For more than two decades, Mamdooh Ghonenum, Ph.D. has been searching to unlock the mystery of why cancer cells weaken to the point of destruction after ingesting common everyday yeast.

At Charles Drew University, Dr. Ghoneum, Ph.D. is well-known for his work as a cancer immunology researcher. He is currently Associate Professor and Chief of Research, Department of Otolaryngology, Head and Neck Surgery. He is also Research Associate at the Department of Neurobiology, School of Medicine, UCLA.

Dr. Ghoneum’s search to develop an effective non-toxic cancer treatment has met with tremendous success in initial stages of animal models. The findings have led to the design of critical clinical trials. 

Born in Egypt, Dr. Ghoneum, earned his Ph.D. at the University of Tokyo, Japan in 1980 and did his postdoctoral at UCLA, School of Medicine.  Dr. Ghoneum is an internationally recognized immunologist who is an expert in the area of Cancer Immune Therapy. He holds three patents for inventing three biological response modifiers for the treatment of cancer. 

Dr. Ghoneum has published more than 90 articles and 130 abstracts, including 11 books in English and Japanese related to cancer immunology.  In 2007, he was nominated for the annual $1 million prestigious Gotham Prize for Cancer Research.

Dr. Ghoneum is a scientist who believes that natural earth holds the secrets to all cures. In fact, one of his most gratifying discoveries in his career was the development of food supplements that have the potential to dramatically improve the immune system’s ability to fight cancer. 

 “I am sure our planet, full of wonders, will uncover more natural agents,” he said. “I've devoted my life to finding and testing them." This is how he came to gest the ancient microbe -- brewer’s yeast in the treatment of cancer.
Dr. Ghoneum was inspired early on in his life when as a child he'd watch his mother take care of others without ever expecting anything in return. He saw how happy it made her to be able to help others.

"She had this great intuition, a natural ability for comforting those around her who were in distress,” said Dr. Ghoneum. “She passed this on to me, because there has been no greater joy in my life than knowing my discoveries, especially since they are non-toxic and less invasive, can help so many.”

His passion for finding a treatment and cure for cancer goes back to when his mentor, a professor at the University of Tokyo died from this disease. His drive has been fueled by the unwavering support of Dr. Gus Gill, then chairman of the Department of Otolaryngology at Charles Drew University. Twenty-five years later, he continues to believe and cultivate Dr. Ghoneum’s research creativity.

The challenge for Charles Drew University and Dr. Ghoneum is in funding this next crucial stage. CDU has invested heavily into its research department, but economic set-backs have slowed advancing the research, and we cannot afford to stop not when Dr. Ghoneum is so close. 
CDU invites you to join our support team. Your donation is tax-deductible to the fullest extent of the law governing California non-profit 501(c) (3) corporations.

We invite you to join CDU to help move this important research forward.  There is no time better than today to make your donation.

It’s time to find a cure.

DONATE TODAY
Dr. Ghoneum’s Curriculum Vitae
Thank you for helping Dr. Ghoneum to advance his search to develop a natural  weapon to fight cancer and prevent future suffering.

Dr. Ghoneum's research has passed initial pre-clinical phases with excellent results.

The next step is to conduct clinical trials to determine the safety and efficacy of dosage and route of treatment. Current clinical trials with yeast have shown oral and enteral administration of yeast is safe in animals. However, the safety of intravenous yeast still needs to be evaluated.

Help make a difference

DONATE TODAY!



Research|Support/Contribute|About CDU |Links|Email Updates| Contact Us | Site Map | Privacy Statement | Terms & Conditions


ABOUT SSL CERTIFICATES

Copyright 2009 Charles Drew University.
Download Adobe Acrobat

This site chose VeriSign SSL for secure e-commerce and confidential communications.
ABOUT SSL CERTIFICATES  

This site is funded by US Department of Education..